par Shekarsarai, H;Zlotta, Alexandre 
;Drowart, Annie ;Van Vooren, Jean-Paul ;De Cock, Michel;Pirson, Michel ;Palfliet, Kamiel;Jurion, F;Vanonckelen, Albert;Simon, Jacques ;Schulman, Claude ;Huygen, Kris
Référence Acta urologica Belgica, 65, 1, page (1-4)
Publication Publié, 1997-03
;Drowart, Annie ;Van Vooren, Jean-Paul ;De Cock, Michel;Pirson, Michel ;Palfliet, Kamiel;Jurion, F;Vanonckelen, Albert;Simon, Jacques ;Schulman, Claude ;Huygen, KrisRéférence Acta urologica Belgica, 65, 1, page (1-4)
Publication Publié, 1997-03
Article révisé par les pairs
| Résumé : | Optimal duration of immunotherapy treatment by BCG for the prevention of recurrences of superficial bladder cancer is still unknown. We have studied the evolution and duration of the cellular immunity response at the peripheral level after BCG intravesical instillations. Our results show that immunity activation after BCG is of short duration and don't take more than 6 months. Our results support, strengthen and partially allow to explain the utility of maintenance treatment by BCG following 6-weekly instillations. |
